Diane Amox

664 total citations
9 papers, 414 citations indexed

About

Diane Amox is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Diane Amox has authored 9 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 2 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Diane Amox's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Lymphoma Diagnosis and Treatment (2 papers). Diane Amox is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Lymphoma Diagnosis and Treatment (2 papers). Diane Amox collaborates with scholars based in United States, Netherlands and Italy. Diane Amox's co-authors include Samuel E. Halpern, J Beauregard, Francesca Giannoni, Salvatore Albani, Berent J. Prakken, Rosario Billetta, Paola Lanza, John F. Scavulli, Charles C. Berry and Margherita Massa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Radiology and Clinical Nuclear Medicine.

In The Last Decade

Diane Amox

9 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane Amox United States 8 171 142 121 88 75 9 414
Kaitlyn Rogers United States 6 336 2.0× 153 1.1× 161 1.3× 138 1.6× 53 0.7× 11 482
Samuel R. Abraham United States 7 106 0.6× 333 2.3× 126 1.0× 91 1.0× 38 0.5× 9 542
Ole Schou Denmark 5 125 0.7× 422 3.0× 68 0.6× 42 0.5× 40 0.5× 13 544
MW Fanger United States 8 118 0.7× 157 1.1× 146 1.2× 71 0.8× 49 0.7× 12 417
G.G. D’Ancona United States 8 164 1.0× 151 1.1× 206 1.7× 58 0.7× 68 0.9× 10 441
D M Goodall United Kingdom 7 259 1.5× 238 1.7× 195 1.6× 19 0.2× 24 0.3× 9 406
Joseph Dal Porto United States 7 119 0.7× 541 3.8× 201 1.7× 71 0.8× 17 0.2× 8 697
Rosa Lovis United States 7 68 0.4× 208 1.5× 114 0.9× 74 0.8× 17 0.2× 9 408
Chisako Iriyama Japan 10 92 0.5× 106 0.7× 154 1.3× 81 0.9× 50 0.7× 17 329
Alexandra Joseph United States 7 40 0.2× 162 1.1× 51 0.4× 166 1.9× 70 0.9× 8 378

Countries citing papers authored by Diane Amox

Since Specialization
Citations

This map shows the geographic impact of Diane Amox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Amox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Amox more than expected).

Fields of papers citing papers by Diane Amox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Amox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Amox. The network helps show where Diane Amox may publish in the future.

Co-authorship network of co-authors of Diane Amox

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Amox. A scholar is included among the top collaborators of Diane Amox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Amox. Diane Amox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Prakken, Berent J., Tho Le, Francesca Giannoni, et al.. (2004). Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proceedings of the National Academy of Sciences. 101(12). 4228–4233. 175 indexed citations
2.
Baird, Stephen M., Michael H. Weisman, Diane Amox, et al.. (1995). Oral 2‐chlorodeoxyadenosine in psoriatic. Arthritis & Rheumatism. 38(11). 1604–1609. 22 indexed citations
3.
Nobori, Tsutomu, Diane Amox, Bruce L. Parker, et al.. (1993). Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers.. PubMed. 53(5). 1098–101. 46 indexed citations
4.
Parker, BA, Artemios B. Vassos, Samuel E. Halpern, et al.. (1990). Radioimmunotherapy of human B-cell lymphoma with 90Y-conjugated antiidiotype monoclonal antibody.. PubMed. 50(3 Suppl). 1022s–1028s. 56 indexed citations
5.
Halpern, Samuel E., Walter Haindl, J Beauregard, et al.. (1988). Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection.. Radiology. 168(2). 529–536. 55 indexed citations
6.
Dillman, Robert O., Sally J. DeNardo, Gerald L. DeNardo, et al.. (1988). Breast cancer imaging with In-111 human IgM monoclonal antibodies: preliminary studies.. Radiology. 167(1). 71–75. 27 indexed citations
7.
Dillman, R O, et al.. (1988). Toxicities associated with monoclonal antibody infusions in cancer patients.. PubMed. 1(2). 81–5. 13 indexed citations
8.
Beauregard, J, et al.. (1987). Radioimmunodetection of cancer with the use of indium-111-labeled monoclonal antibodies.. PubMed. 33–6. 19 indexed citations
9.
Haindl, Walter, Samuel E. Halpern, Robert O. Dillman, et al.. (1986). RADIOIMMUNOIMAGING OF TUMORS WITH INDIUM-111 LABELED F(abʼ)2 ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY.. Clinical Nuclear Medicine. 11(Supplement). P14–P14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026